Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C MacDougall

Showing results (221-230 of 373) with videos related to

Pageof 38
Sort By:
Contributions to Nephrology|January 1, 1989
Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatmentI C Macdougall, D E Roberts, P Neubert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 17-18: adverse effectsW H Hörl, C Jacobs, I C Macdougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 1-4: evaluating anaemia and initiating treatmentF Valderrábano, W H Hörl, C Jacobs, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 9-13: anaemia managementC Jacobs, W H Hörl, I C Macdougall, et al.
European Journal of Clinical Investigation|July 1, 1993
Effects of the correction of renal anaemia by erythropoietin on physiological changes during exerciseN P Lewis, I C Macdougall, N Willis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 13, 2012
Evaluation of a pragmatic exercise rehabilitation programme in chronic kidney diseaseSharlene A Greenwood, Herolin Lindup, Kevin Taylor, et al.
Lancet (London, England)|February 25, 1989
Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysisI C Macdougall, D E Roberts, P Neubert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 5: target haemoglobinC Jacobs, W H Hörl, I C Macdougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 14-16: inadequate response to epoetinW H Hörl, C Jacobs, I C Macdougall, et al.
Journal of Blood Medicine|October 17, 2017
Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactionsN Franklin Adkinson, William E Strauss, Kristine Bernard, et al.
Pageof 38

Showing results (221-230 of 373) with videos related to

Sort By:
Pageof 38
Contributions to Nephrology|January 1, 1989
Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatmentI C Macdougall, D E Roberts, P Neubert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 17-18: adverse effectsW H Hörl, C Jacobs, I C Macdougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 1-4: evaluating anaemia and initiating treatmentF Valderrábano, W H Hörl, C Jacobs, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 9-13: anaemia managementC Jacobs, W H Hörl, I C Macdougall, et al.
European Journal of Clinical Investigation|July 1, 1993
Effects of the correction of renal anaemia by erythropoietin on physiological changes during exerciseN P Lewis, I C Macdougall, N Willis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 13, 2012
Evaluation of a pragmatic exercise rehabilitation programme in chronic kidney diseaseSharlene A Greenwood, Herolin Lindup, Kevin Taylor, et al.
Lancet (London, England)|February 25, 1989
Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysisI C Macdougall, D E Roberts, P Neubert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 5: target haemoglobinC Jacobs, W H Hörl, I C Macdougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2000
European best practice guidelines 14-16: inadequate response to epoetinW H Hörl, C Jacobs, I C Macdougall, et al.
Journal of Blood Medicine|October 17, 2017
Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactionsN Franklin Adkinson, William E Strauss, Kristine Bernard, et al.
Pageof 38